Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Tyrosine Kinase Inhibitors
×
Myeloid
×
Clear all
Filters
3
NCT05476562
2022-11-08
Study Conducted Among Patients With CML
Novartis
Completed
3,234 enrolled